secwatch.observer — SEC 8-K summary
======================================

Issuer:     Chemomab Therapeutics Ltd. (CMMB)
CIK:        0001534248
Form:       8-K
Filed at:   2022-06-21T23:59:59+00:00
Accession:  0001178913-22-002410
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Chemomab appoints Jill M. Quigley to board of directors
-------------------------------------------------------

- Jill M. Quigley appointed to Chemomab board and audit committee, effective June 16, 2022.
- Quigley brings 20+ years biotech experience, including COO of Passage Bio and CEO of Nutrinia.
- Board expands to seven directors; audit committee now includes Quigley as financial expert.
- Quigley also serves on Terns Pharmaceuticals board (TERN) and chairs its audit committee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534248/000117891322002410/0001178913-22-002410-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534248/000117891322002410/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001178913-22-002410

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer